Diagnostic Medical Systems (LTS:0RIA) ROCE % : -8.20% (As of Jun. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Diagnostic Medical Systems ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Diagnostic Medical Systems's annualized ROCE % for the quarter that ended in Jun. 2024 was -8.20%.

Diagnostic Medical Systems ROCE % Historical Data

The historical data trend for Diagnostic Medical Systems's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnostic Medical Systems ROCE % Chart

Diagnostic Medical Systems Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-15.25

-14.38

-7.78

-21.11

-32.01

Diagnostic Medical Systems Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial															-24.09	-14.98	28.00	-92.99	-8.20

Diagnostic Medical Systems ROCE % Calculation

Diagnostic Medical Systems's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-9.378	/	( ( (53.892 - 24.413)	+	(51.138 - 22.017) )	/ 2 )
	=	-9.378	/	( (29.479	+	29.121)	/ 2 )
	=	-9.378	/	29.3
	=	-32.01 %

Diagnostic Medical Systems's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	-2.292	/	( ( (51.138 - 22.017)	+	(49.614 - 22.861) )	/ 2 )
	=	-2.292	/	( ( 29.121	+	26.753 )	/ 2 )
	=	-2.292	/	27.937
	=	-8.20 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Diagnostic Medical Systems (LTS:0RIA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Diagnostic Medical Systems ROCE % Related Terms

Thank you for viewing the detailed overview of Diagnostic Medical Systems's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Diagnostic Medical Systems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Diagnostic Medical Systems (LTS:0RIA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

ALDMS:France DMS1:Germany

Address

9 Avenue du Canal Philippe, Gallargues le Montueux, FRA, FR-30660

Website

https://www.dms.com

Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.

Diagnostic Medical Systems Headlines

No Headlines